Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002026410-24-000001
Filing Date
2024-12-17
Accepted
2024-12-17 16:25:43
Documents
1
Effectiveness Date
2024-12-17
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 16532
  Complete submission text file 0002026410-24-000001.txt   17677
Mailing Address 345 PARK AVENUE NEW YORK NY 10154
Business Address 345 PARK AVENUE NEW YORK NY 10154 212-583-5000
Blackstone Life Sciences VI (LUX) SCSp (Filer) CIK: 0002026410 (see all company filings)

EIN.: 981786671 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-532387 | Film No.: 241556056